Immucor, Inc.NASDAQ
BLUD is defunct.
  • Jul. 5, 2011, 10:16 AM

    TPG's acquisition of Immucor (BLUD +30%) fails to spur comparables Bio-Rad Laboratories (BIO -0.7%) and Gen-Probe (GPRO -1.1%). Takeout multiples were below current diagnostics multiples, Leerink notes, and the P-E buyout likely means there was little interest in BLUD from strategic acquirers.

    | Jul. 5, 2011, 10:16 AM | 1 Comment
  • Jul. 5, 2011, 8:05 AM

    Immucor (BLUD) to be acquired by TPG Capital for $27/share in cash ($1.97B). Immucor makes equipment used by blood banks, hospitals, and labs to test blood prior to transfusions. (PR) Good call by Andrew August back in March.

    | Jul. 5, 2011, 8:05 AM | 1 Comment